Clinical Trials Logo

Filter by:
NCT ID: NCT05869266 Completed - Hearing Loss Clinical Trials

Tuned App Self-Fitting vs. Professional Fitting

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to compare the perceived outcome of the self-fitting performed by the participants using the Tuned mobile application with the traditional professional fitting as performed by a licensed professional audiologist in subjects with mild to moderate sensorineural hearing loss.

NCT ID: NCT05861661 Completed - Anorexia Nervosa Clinical Trials

Social Cognition in Patients With Anorexia Nervosa- the Study Examines Social Understanding in Patients With AN Via Questionnaire and Computer Tasks

Start date: July 12, 2020
Phase:
Study type: Observational [Patient Registry]

The current research has two goals: first to validate the Hebrew version of a new measurement for assessing mentalization failures. The second goal is to examine the connection between attachment, emotional regulation strategies, mentalization, and specific mentalization failures - As they manifested in anorexia nervosa (AN) compared with non-patient controls. The study includes computer tasks, questionnaires and two short tasks administrated by the examiner.

NCT ID: NCT05850767 Completed - Healthy Clinical Trials

The Effect of Sleep Deprivation on Passive and Active Functions and Distance Modulation of the Vestibulo-Ocular Reflex

Start date: May 19, 2022
Phase: N/A
Study type: Interventional

The goal of this cross-over clinical trial is to evaluate the effect of 24 hours sleep deprivation on the Vestibulo-Ocular Reflex (VOR) in healthy participants. The main questions it aims to answer are: 1. The effect of sleep deprivation on vestibular function. 2. The difference between passive and active VOR function following sleep deprivation. 3. The vergence mediated modulation ability of the VOR following sleep deprivation. 4. The effect of sleep deprivation on behavioral VOR function. Participants will be tested before and after a normal night sleep and during 24 hours of sleep deprivation.

NCT ID: NCT05846308 Completed - Clinical trials for Autism Spectrum Disorder

The Effectiveness of Group Interpersonal Synchrony in Young Autistic Adults' Work Environment

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Background: Few autistic adults are able to integrate successfully into the world of work given their difficulties adapting to the social and stressful aspects of work environments. Interpersonal synchrony, when two or more individuals share body movements or sensations, is a powerful force that consolidates human groups while promoting the ability to self-regulate and cooperate with others. The abilities to self-regulate and cooperate are crucial for maintaining a calm and productive work environment. Objectives: This randomized controlled trial (RCT) aims to assess the effects of group interpersonal synchrony on prosociality and work-related stress of young autistic adults in their work environment. Methods: This mixed-methods RCT will investigate two movement-based group synchronous and non-synchronous intervention conditions. The sample will be composed of young adults enrolled in an innovative Israeli program designed to integrate cognitively-abled 18- to 25-year-old autistic adults into the Israeli army work force. The movement-based intervention sessions will take place in groups of 10-14 participants, once a week for 10 weeks. Questionnaires, behavioral collaborative tasks and semi-structured interviews will be conducted. Quantitative data will be collected for each participant at three points of time: before and after the intervention period, and four months after the end of the intervention. Qualitative data will be collected after the intervention period in interviews with 15% of the participants.

NCT ID: NCT05843201 Completed - Clinical trials for Chronic Heart Failure

AquaPass Device in Treatment of CHF Patients

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

The AquaPass System is intended for enhancing fluid transfer through the skin, by increased sweat rate, in fluid overloaded patients. This study will examine safety, performance and usability of the AquaPass device in two phases: Phase 1: Hospitalization treatment. Phase 2: Home/outpatient clinic treatment

NCT ID: NCT05842720 Completed - Clinical trials for Patient Satisfaction

Consented Unsedated Endoscopy in High Risk Patients That Require Anesthesiologist Observation During the Procedure

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

This study aim to examine the safety and feasibility of unsedated colonoscopy in patients with high risk for sedation (ASA scoreā‰„3).

NCT ID: NCT05824156 Completed - Clinical trials for Nonalcoholic Steatohepatitis

CM-101 in NASH Patients - The SPLASH Study

Start date: February 24, 2021
Phase: Phase 2
Study type: Interventional

This phase 2a study is a multi-center, double-blind randomized, placebo-controlled study. The study is designed to determine the safety and tolerability of the anti-human CCL24 monoclonal antibody CM-101 in adult patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) patients with stage 1c, 2 or 3 fibrosis. The patients will be randomized to 1 of 2 treatment groups: 5 mg/kg CM-101 or placebo.

NCT ID: NCT05799677 Completed - Reflexology Clinical Trials

The Effect of Reflexology in Patients With Viral Bronchiolitis

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

To test the influence of reflexology on bronchiolitis.

NCT ID: NCT05777785 Completed - ADHD Clinical Trials

A Novel Device for the Management of ADHD

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This is a 2-months study, where eligible ADHD adult participants will be provided with personalized VIZO glasses.

NCT ID: NCT05769322 Completed - Migraine Clinical Trials

Real World Data Analysis: Impact of High-Frequency REN Treatments as Migraine Preventive Therapy in Adolescence

Start date: April 1, 2023
Phase:
Study type: Observational

This is a post-marketing study investigating the safety and efficacy of the REN device (Nerivio by Theranica, ISRAEL) in adolescents with migraine. The data analysis will test the ability of Frequent use of REN for the acute treatment of migraine to reduce the number of monthly migraine days in subsequent months, suggesting potential preventive benefits.